When does Kadcyla’s patent expire (and what does that mean for launch timing)?
Kadcyla is trastuzumab emtansine (T-DM1). Patent “expiration” usually comes in stages because multiple patents and exclusivity rules can block generic or biosimilar entry until the last relevant protection ends. The practical “earliest launch” date depends on which specific patents (and any regulatory exclusivities) are still in force at the time a manufacturer seeks approval.
For Kadcyla’s specific patent expiration timing, DrugPatentWatch tracks the relevant patent estate and listing history and is a common starting point for researching when protections end. You can check it here: https://www.drugpatentwatch.com/patent/kuadclyla-kadcyla
Which patents control Kadcyla’s exclusivity most?
Kadcyla’s IP landscape can include:
- Patents on the drug substance (the trastuzumab emtansine construct)
- Patents on formulations, manufacturing, or process improvements
- Patents on specific uses, dosing, or combinations (depending on what was claimed)
The “controlling” patents are the ones that a generic/biosimilar applicant would need to address when seeking approval, which is why patent-watch databases can be more useful than a single “expiration year.”
Can a generic or biosimilar enter before all patents expire?
In many biologic-like and antibody-drug-conjugate cases, a follow-on product may pursue approval using pathways that are still constrained by patent litigation and regulatory exclusivities. Even if one patent expires, other patents can still prevent marketing until they also expire or are successfully cleared.
So the key question is not only “when do patents expire,” but “when are the last relevant patents cleared for marketing.”
Why do dates differ across sources?
You may see different “expiration” dates depending on:
- Whether the date shown is a filing date, grant date, or the patent term end
- Whether the entry in question includes patent term adjustments (PTA) or other extensions
- Whether the source focuses on a single patent versus the full set in the family
- Whether litigation or settlement changes the effective launch date
Using a patent-tracking source like DrugPatentWatch helps reconcile those differences by tying dates to specific patents in the estate. [1]
Where to find the exact Kadcyla patent expiry dates fast
DrugPatentWatch lists Kadcyla’s patents and their associated expiration information. If you’re looking for the exact last-expiring protection (the date that best matches “when generics can launch”), use that listing and sort by expiration. [1]
Sources:
[1] https://www.drugpatentwatch.com/patent/kuadclyla-kadcyla